By: Akoi M. Baysah, Jr.
The United States Government has handed over more than 40,000 doses of monkeypox vaccines to the Government of Liberia, strengthening the country’s response to the rising number of monkeypox cases.
The handover ceremony, held last week, was led by U.S. Chargé d’Affaires Joe Zadrozny, marking another milestone in the long-standing U.S.–Liberia health partnership.
The vaccine delivery is aimed at boosting Liberia’s capacity to contain the outbreak, particularly in hotspot communities, and to support vaccination efforts for contacts of confirmed cases and other at-risk populations.
According to a post on the US Embassy official Facebook page, the vaccines were provided with technical support from the U.S. Centers for Disease Control and Prevention (CDC) in close collaboration with Liberia’s Ministry of Health and the National Public Health Institute of Liberia (NPHIL).
Speaking on the initiative, U.S. officials emphasized that helping partner countries stop outbreaks at their source is critical to protecting Americans at home and abroad.
They noted that strong public health systems save lives, promote stability, and enhance global health security.
The United States also commended Liberia’s health professionals and partners for their leadership and frontline efforts in managing public health threats, reaffirming its commitment to continued, accountable, and results-driven cooperation in advancing health security.
The latest support underscores ongoing U.S. engagement in strengthening Liberia’s health system and preparedness for emerging and re-emerging infectious diseases.
